The survey for anti-emetic guideline by using questioner

Toshiaki Saeki, Kazuo Tamura, Keisuke Aiba, Kenjiro Aogi, Keiko Lino, Chiyo Imamura, Kenji Eguchi, Kenji Okita, Yoshikazu Kagami, Ryuhei Tanaka, Kazuhiko Nakagawa, Hirofumi Fujii, Narikazu Boku, Kazuo Matsuura, Makoto Wada, Tatsuo Akechi, Yuichi Kakudo, Yong Il Kim, Hide Nori Sasaki, Yasuo ShimaMasayuki Takeda, Eijiro Nagasaki, Toshihiko Nishidate, Mitsue Saito, Yukino Ashikaga, Yusuke Tanigawara, Koichi Hirata, Chikashi Ishioka, Masahiko Nishiyama

Research output: Contribution to journalReview article

Abstract

Background: Japan Society of Clinical Oncology published a guideline for anti-emetic therapy two years ago. This guideline was a first evidence based guideline of anti-emetic treatment for the patients who received chemotherapy in Japan. To investigate a current situation of anti-emetic treatment in Japan, we analyzed the data from nationwide questionnaire. Material: Questionnaire analysis; From June 2012 to August 2012, we gave 24 questionnaires on the Japan Society of Clinical Oncology Website and collected the response from the member of 5 major academic oncology societies. The questionnaires included degree of recognition, penetration, usefulness, problems and user type of medial stuff for the anti-emetic guideline published by (JSCO). Results: Questionnaire; 1,529 medical stuff responded to our questionnaire. 1,308 (85.5%) stuffs recognized JSCO guidelines, 586 (51%) had regard for guideline and 489 (42.6%) referred to the guideline. 899 (78.3%) changed their practice in clinic to recommended practice by the guideline. But 385 (33.5%) complained high medical cost of recommended anti-emetic therapy. Conclusions: Degree of recognition and penetration of our guideline for anti-emetic therapy were very high in Japan.

Original languageEnglish
Pages (from-to)305-311
Number of pages7
JournalJapanese Journal of Cancer and Chemotherapy
Volume42
Issue number3
Publication statusPublished - 2015 Mar 1

Keywords

  • Anti-emetic guideline
  • Questionnaire

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'The survey for anti-emetic guideline by using questioner'. Together they form a unique fingerprint.

  • Cite this

    Saeki, T., Tamura, K., Aiba, K., Aogi, K., Lino, K., Imamura, C., Eguchi, K., Okita, K., Kagami, Y., Tanaka, R., Nakagawa, K., Fujii, H., Boku, N., Matsuura, K., Wada, M., Akechi, T., Kakudo, Y., Kim, Y. I., Sasaki, H. N., ... Nishiyama, M. (2015). The survey for anti-emetic guideline by using questioner. Japanese Journal of Cancer and Chemotherapy, 42(3), 305-311.